Innovation Pharmaceuticals' Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line
Stock Information for Innovation Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.